Description

Oxfenicine (CAS 32462-30-9) is a high-purity biochemical compound with the molecular formula C₈H₉NO₃ and the IUPAC name (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid. This white to off-white crystalline powder is a derivative of phenylglycine, specifically the L-enantiomer of 4-hydroxyphenylglycine, making it a valuable chiral building block in pharmaceutical synthesis and metabolic research. With a molecular weight of 167.16 g/mol, Oxfenicine exhibits excellent solubility in aqueous solutions and select organic solvents, facilitating its use in various experimental protocols. Our product is rigorously tested via HPLC (>98% purity) and meets stringent quality control standards for research applications. Suitable for use as a reference standard, metabolic modulator, or intermediate in drug discovery, this compound is packaged under inert conditions to ensure stability and longevity.

Properties

• CAS Number: 32462-30-9
• Complexity: 164
• IUPAC Name: (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid
• InChI: InChI=1S/C8H9NO3/c9-7(8(11)12)5-1-3-6(10)4-2-5/h1-4,7,10H,9H2,(H,11,12)/t7-/m0/s1
• InChI Key: LJCWONGJFPCTTL-ZETCQYMHSA-N
• Exact Mass: 167.058243149
• Molecular Formula: C8H9NO3
• Molecular Weight: 167.16
• SMILES: C1=CC(=CC=C1[C@@H](C(=O)O)N)O
• Topological: 83.6
• Monoisotopic Mass: 167.058243149
• Synonyms: 32462-30-9, OXFENICINE, L-4-Hydroxyphenylglycine, Oxfenicina, (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid, L-2-(p-Hydroxyphenyl)glycine, (2s)-Amino(4-Hydroxyphenyl)Acetic Acid, Oxfenicinum, (s)-(4-hydroxyphenyl)glycine, L-2-(4-Hydroxyphenyl)glycine, p-Hydroxy-L-phenylglycine, Oxfenicinum [INN-Latin], UK-25842, (2S)-amino(4-hydroxyphenyl)ethanoic acid, Oxfenicina [INN-Spanish], Oxfenicine [USAN:INN:BAN], 4-hydroxyphenylglycine, (s)-, 9YH0WH2Z02, DTXSID3046403, CHEBI:31755, UK-25,842, OXFENICINE [INN], EINECS 251-061-7, OXFENICINE [USAN], (S)-alpha-Amino-4-hydroxybenzeneacetic acid, (S)-2-Amino-2-(4-hydroxyphenyl)essigsaeure, DTXCID1026403, Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (S)-, Oxfenicinum (INN-Latin), Oxfenicina (INN-Spanish), AMOXICILLIN SODIUM IMPURITY I [EP IMPURITY], Benzeneacetic acid, alpha-amino-4-hydroxy-, (S)-, AMOXICILLIN SODIUM IMPURITY I (EP IMPURITY), (2S)-2-azaniumyl-2-(4-hydroxyphenyl)acetate, 251-061-7, 4-Hydroxy-L-phenylglycine, H-Phg(4-OH)-OH, (S)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID, (S)-Amino-(4-hydroxyphenyl)acetic acid, 4-Hydroxy-L-(+)-2-phenylglycine, Oxfenicine (USAN/INN), L-P-HYDROXYPHENYGLYCINE, (S)-4-hydroxyphenylglycine, MFCD00065932, CAS-32462-30-9, UNII-9YH0WH2Z02, L-(+)-p-Hydroxyphenylglycine, NCGC00164509-01, L-Hydroxyphenylglycine, bmse000629, SCHEMBL122315, CHEMBL1232077, Tox21_112144, BDBM50403035, L-(+)-2-(4-Hydroxyphenyl)glycine, MSK165522, AKOS016842371, Tox21_112144_1, CS-W018812, DB04291, HY-W018026, NCGC00344518-01, AC-24628, DS-11081, H1389, NS00070321, 4-Hydroxy-L-phenylglycine, >=99.0% (NT), D05292, EN300-198950, (S)-(+)-2-Amino-2-(4-hydroxyphenyl)acetic Acid, Q27095113, Z1255364887

Application

Oxfenicine serves as a key intermediate in the synthesis of beta-lactam antibiotics and other chiral pharmaceuticals. Researchers utilize this compound to study cardiac metabolism due to its role as a carnitine palmitoyltransferase-1 (CPT-1) inhibitor, modulating fatty acid oxidation pathways. In preclinical studies, it has shown potential as a metabolic modulator for improving myocardial efficiency under ischemic conditions.

Safety and Hazards

GHS Hazard Statements

• H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]
• H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
• H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
• H335 (97.5%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

Precautionary Statements

• P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

• Acute Tox. 4 (97.5%)
• Skin Irrit. 2 (100%)
• Eye Irrit. 2A (100%)
• STOT SE 3 (97.5%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.